|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02225 JINHAI MED TECH
Nominal 
1.050 0.000 (0.000%) | 2024/12 - Final SGD(K$) | %Chg (Compare to Final) | 2023/12 SGD(K$) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | |
| Turnover | 50,241 | 10.071% | 45,644 | 22,280 | 21,896 | 22,472 |
| Cost of Sales | (38,764) | 15.318% | (33,615) | (12,164) | (14,169) | (13,617) |
| Gross Profit | 11,477 | -4.589% | 12,029 | 10,116 | 7,727 | 8,855 |
| 2024/12 - Final SGD(K$) | %Chg (Compare to Final) | 2023/12 SGD(K$) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (18,227) | 466.584% | (3,217) | 784 | (62) | 1,426 | |
| Taxation | (28) | -96.872% | (895) | (668) | (435) | (163) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 290 | -70.134% | 971 | 352 | 252 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (17,965) | 471.952% | (3,141) | 468 | (246) | 1,263 | |
| 2024/12 - Final SGD(K$) | %Chg (Compare to Final) | 2023/12 SGD(K$) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | |
| Net Finance Costs / (Income) | 755 | 357.576% | 165 | 74 | 130 | 314 |
| Depreciation & Amortisation | 5,019 | 22.355% | 4,102 | 4,386 | 5,366 | 6,260 |
| Directors' Emoluments | 1,876 | 191.757% | 643 | 909 | 1,163 | 1,208 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -0.350 | 483.333% | -0.060 | 0.010 | -0.005 | 0.025 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.001) | -- | 0.000 | 0.003 | 0.003 | 0.006 |
| NBV per share ($) | 0.006 | -- | 0.007 | 0.004953 | 0.004934 | 0.005181 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | SGD -10,253 |
| %Change | 69.667% |
| EPS / (LPS) | SGD -0.002 |
| NBV Per Share ($) | SGD 0.005 |